Altrinsic Global Advisors’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-120,000
Closed -$520K 55
2021
Q4
$520K Hold
120,000
0.02% 73
2021
Q3
$611K Hold
120,000
0.02% 77
2021
Q2
$760K Hold
120,000
0.02% 76
2021
Q1
$928K Buy
+120,000
New +$928K 0.03% 76